The requirements may include: BMI greater than 27 with a co-morbidity or a BMI greater than 30 without Mandate that patient participate in a weight loss management program Ultimately, plans that cover GLP-1s for weight loss want their members to know that the company supports them
One clinical trial indicated only about 86 percent of the more than 800 participants achieved clinically significant weight loss after taking semaglutide, sold under the brands Ozempic and Wegovy, for 68 weeks, which means a portion of users did not
What to Look for in a Provider When considering options for support, choose a provider who has: Deep experience in metabolic medicine, obesity, and hormonal care
Remote medication adherence through Ash Wellness helps break down barriers to care for low-income patients and others who cannot routinely visit an in-person phlebotomist for lab testing
50 , D543D552 (2022)
A recent genome-wide association study also identified the gene NBEA (neurobeachin) as likely contributing to differences in weight loss on GLP-1s